The research was co-led by Prof. Valeriya Malysheva, group leader at the VIB-UAntwerp Center for Molecular Neurology, and focuses on type 3 innate lymphoid cells, or ILC3s. These specialized immune cells are found at barrier tissues including the intestine, where they help coordinate inflammation, maintain tissue integrity and support repair. Because ILC3s are relatively uncommon, however, scientists have had difficulty obtaining enough material to examine their gene-regulatory architecture using conventional genomic technologies.

That limitation is important because many disease-associated genetic variants do not alter the protein-coding sequence of a gene. Instead, they occur in regulatory regions such as enhancers, which can control gene activity from a considerable distance. Identifying the gene influenced by a regulatory variant is therefore not straightforward. The relevant DNA elements may lie thousands or even millions of DNA letters away from their target genes in the linear genome, while their physical interaction inside the nucleus can provide a direct clue to the underlying mechanism.

To overcome the problem of limited cell numbers, the researchers used miniaturized Capture Hi-C, a method developed by Malysheva during her postdoctoral work at the MRC Laboratory of Medical Sciences in the United Kingdom. Hi-C-based methods measure contacts between different regions of the genome by capturing and sequencing DNA fragments that have been close together in the nucleus. Capture Hi-C adds a targeted enrichment step, allowing investigators to examine selected genomic regions with greater sensitivity. The miniaturized version reduces the number of cells required, making high-resolution analysis possible in rare populations such as ILC3s.

The team applied the method to map promoter interactions across the ILC3 genome. Promoters are regulatory DNA regions positioned near genes and help initiate transcription, the process by which DNA instructions are copied into RNA. By determining which disease-associated regulatory regions physically contact which promoters, the researchers were able to connect genetic variants linked to Crohn’s disease risk with candidate target genes. This approach provided information that could not be obtained from genetic association studies alone, because statistical links between variants and disease do not automatically reveal the genes or cell types involved.

The analysis identified more than 100 genes in ILC3s that may be influenced by regulatory variants associated with Crohn’s disease. Approximately half had already been implicated in the disease, supporting the validity of the regulatory maps. The remaining genes had not previously been connected to Crohn’s disease, expanding the list of potential biological targets for future investigation. The findings also suggest that genetic risk may be concentrated in specific immune-cell states rather than distributed uniformly across all cell types.

One of the most unexpected candidates was CLN3, a gene best known for its connection to Batten disease, a rare inherited neurodegenerative disorder. The study’s follow-up experiments indicated that CLN3 directly affects how strongly ILC3s produce inflammatory signals. This result places the gene in an immune-regulatory context that had not been fully appreciated and highlights how disease biology can cross traditional boundaries between organ systems. A gene associated primarily with the nervous system may also influence the behavior of immune cells in the intestine.

The findings do not mean that CLN3 alone causes Crohn’s disease, nor that every genetic variant identified will produce the same effect in every person. Crohn’s disease is a complex condition shaped by many genetic factors, immune pathways, environmental influences and interactions with the gut microbiome. Rather, the study provides a mechanistic framework for understanding how non-coding variants may alter gene regulation in a cell type that participates directly in intestinal inflammation. These insights could eventually help researchers prioritize therapeutic targets or identify disease mechanisms that are missed in studies of more abundant immune cells.

More broadly, the work demonstrates the value of combining genetic data with cell-specific maps of three-dimensional DNA organization. Genome-wide association studies can identify regions associated with disease, but functional interpretation requires knowing when, where and how those regions regulate genes. By making promoter interaction analysis feasible in scarce cell populations, miniaturized Capture Hi-C offers a way to connect statistical genetic signals to cellular processes. The researchers’ results provide a detailed view of ILC3 regulation and may guide similar studies of rare immune cells involved in autoimmune disorders beyond Crohn’s disease.

Journal: Nature Genetics
Article Title: High-resolution promoter interaction analysis implicates genes involved in activation of type 3 innate lymphoid cells in immune disease risk
News Publication Date: 4 August 2026
Web References: https://doi.org/10.1038/s41588-026-02681-0
References: https://doi.org/10.1038/s41588-026-02681-0
Keywords: Crohn’s disease, autoimmune disease, type 3 innate lymphoid cells, ILC3s, three-dimensional genome organization, Capture Hi-C, gene regulation, CLN3, immunology, genetics, inflammatory signaling

Psoriasis, characterized by rapid epidermal cell proliferation and chronic inflammation, has long been understood to result from a complex interplay of genetic predispositions and environmental triggers, including lifestyle factors like smoking and diet. However, until now, the impact of stress experienced specifically during infancy remained unexplored in the context of psoriasis risk. Prior investigations had primarily focused on stress experienced immediately before clinical onset, leaving a critical gap regarding the implications of early developmental stressors on immune dysregulation.

The cohort analysis utilized data from the extensive All Babies in Southeast Sweden longitudinal birth study, encompassing over 17,000 children monitored from infancy into later childhood. Researchers meticulously cataloged stressful life factors at critical timepoints — ages one, three, five, and eight years — and cross-referenced these with subsequent psoriasis diagnoses. Among the cohort, 121 children were identified as having developed psoriasis, with the study pinpointing early family structure change as the most potent predictor of disease risk. This indicates that the neonate’s exposure to familial upheaval during a sensitive developmental window exerts durable immunological consequences.

Lead investigator Johnny Ludvigsson, MD, PhD, of Linköping University’s Division of Pediatrics, emphasized the biological plausibility underpinning these results. He explained that disruptions such as parental divorce or bereavement induce acute psychological distress during a period when the neuroendocrine and immune systems are highly malleable. This acute stress provokes a defensive physiological response characterized by heightened cortisol levels. Cortisol, a glucocorticoid hormone, is known to modulate immune function and, under chronic elevation, may dysregulate immune homeostasis, favoring autoimmunity and inflammatory processes that manifest as skin pathology like psoriasis.

The timing of these stress exposures is critical, as the infant immune system is undergoing rapid maturation. Stress during this narrow temporal window can derail normative immune development, altering T-cell activation thresholds and cytokine profiles that predispose individuals to immune-mediated diseases. The findings challenge previous assumptions that genetic and later life environmental influences solely determine psoriasis susceptibility, demonstrating instead that early psychosocial context plays a foundational role in programming immune tolerance and reactivity.

Notably, the investigators caution that the study population’s demographic homogeneity—a largely ethnically uniform group in southeastern Sweden—may limit the broad application of these findings. Future research across more diverse populations will be essential to validate the universality of this stress-psoriasis link. Nonetheless, the robust longitudinal methodology lends compelling temporal and causal credibility to the association between infant stressful life factors and autoimmune risk.

Prominent dermatology experts welcome these findings for their novel insights and practical implications. Dr. Luigi Naldi, a leading researcher from Italy’s IRCCS Ospedale San Raffaele, described this work as advancing our understanding of how early-life experiences imprint immune regulation to shape chronic disease risk. He highlights how this study employs population-based registries and longitudinal tracking, which uniquely illuminate the neuroendocrine-immune developmental axis during critical periods that have traditionally been overlooked in psoriasis research.

Similarly, Dr. Yi Xiao, Deputy Director at Xiangya Hospital’s Key Laboratory of Skin Cancer and Psoriasis in China, underscores the importance of integrating social and environmental risk factors in both clinical and public health approaches to psoriasis prevention. She advocates for complementary care pathways that move beyond genetic and lifestyle modifications to encompass early psychosocial interventions that promote emotional security and family stability.

The mechanisms linking stress to autoimmunity involve complex shifts in immune cell phenotypes and cytokine production, mediated by the hypothalamic-pituitary-adrenal (HPA) axis and its downstream effectors like cortisol. Elevated cortisol under chronic stress can suppress regulatory T-cell function and enhance pro-inflammatory pathways such as the Th17 axis, which is critically involved in psoriasis pathogenesis. This immunomodulatory disruption perpetuates the cycle of inflammation, leading to characteristic skin lesions and systemic involvement over time.

The findings raise profound questions about the role of early childhood environments in sculpting lifelong health trajectories, bridging psychosocial science with immunology. Intervention strategies aimed at minimizing early life stressors, such as supporting family stability, mental health services, and social policies that protect vulnerable children, may emerge as vital components in reducing the incidence of autoimmune diseases like psoriasis. While there is no straightforward method to eliminate such stressors entirely, heightened awareness and preventative measures could mitigate their immunological impact.

In sum, this study redefines psoriasis risk factors to encompass early psychosocial exposures, shifting paradigms in dermatological research and preventive medicine. The entwined biological and social determinants of health illuminated here call for interdisciplinary strategies targeting the earliest stages of human development. As the research community continues to decode the nexus between early life stress and immune dysfunction, these insights pave the way for innovative approaches that prioritize emotional well-being as an integral aspect of autoimmune disease prevention.

These revelations encourage a reevaluation of current clinical practice and public health frameworks, recognizing that the seeds of chronic immunological disorders may be sown far earlier than previously realized. The integration of psychosocial care with medical management could transform outcomes for patients predisposed to psoriasis, highlighting the power of nurturing secure and stable childhood environments in shaping robust immune health.

Subject of Research: People

Article Title: Early Childhood Stress and the Risk of Developing Psoriasis: A Cohort Study

News Publication Date: October 21, 2025

Web References:

• Journal of Investigative Dermatology: https://www.jidonline.org/
• DOI Link: http://dx.doi.org/10.1016/j.jid.2025.08.026

Image Credits: Journal of Investigative Dermatology / Das/Ludvigsson

Keywords: Psoriasis, Autoimmune disease, Early childhood stress, Family structure change, Cortisol, Immune system, Neuroendocrine-immune axis, Longitudinal cohort study, Pediatric immunology, Autoimmune risk factors, Psychosocial determinants, Dermatology research